107 related articles for article (PubMed ID: 15658507)
21. Endogenous opiates and behavior: 2013.
Bodnar RJ
Peptides; 2014 Dec; 62():67-136. PubMed ID: 25263178
[TBL] [Abstract][Full Text] [Related]
22. Possible involvement of endogenous nociceptin/orphanin FQ in the pain-related behavioral responses induced by its own metabolite, nociceptin/orphanin FQ(14-17).
Watanabe H; Mizoguchi H; Orito T; Katsuyama S; Yonezawa A; Watanabe C; Sakurada T; Sakurada S
Peptides; 2007 Mar; 28(3):670-7. PubMed ID: 17196303
[TBL] [Abstract][Full Text] [Related]
23. Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test.
Sandrini M; Vitale G; Pini LA; Lopetuso G; Romualdi P; Candeletti S
Eur J Pharmacol; 2005 Jan; 507(1-3):43-8. PubMed ID: 15659293
[TBL] [Abstract][Full Text] [Related]
24. A neuropeptide-centric view of psychostimulant addiction.
Boutrel B
Br J Pharmacol; 2008 May; 154(2):343-57. PubMed ID: 18414383
[TBL] [Abstract][Full Text] [Related]
25. Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling.
Wenzel JM; Cheer JF
Neuropsychopharmacology; 2018 Jan; 43(1):103-115. PubMed ID: 28653666
[TBL] [Abstract][Full Text] [Related]
26. The dopamine D3 receptor and drug dependence: effects on reward or beyond?
Le Foll B; Goldberg SR; Sokoloff P
Neuropharmacology; 2005 Sep; 49(4):525-41. PubMed ID: 15963538
[TBL] [Abstract][Full Text] [Related]
27. Effect of supraspinal Nocistatin on Nociceptin/Orphanin FQ antagonism of selective opioid analgesia.
Scoto GM; Santangelo N; Parenti C
Neurosci Lett; 2005 Oct; 387(3):126-9. PubMed ID: 16006036
[TBL] [Abstract][Full Text] [Related]
28. Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ.
Berger H; Albrecht E; Wallukat G; Bienert M
Br J Pharmacol; 1999 Feb; 126(3):555-8. PubMed ID: 10188961
[TBL] [Abstract][Full Text] [Related]
29. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
Lutfy K; Maidment NT
Br J Pharmacol; 2000 Dec; 131(8):1684-8. PubMed ID: 11139447
[TBL] [Abstract][Full Text] [Related]
30. Role of Nociceptin/Orphanin FQ in the physiologic and pathologic control of the cerebral circulation.
Armstead WM
Exp Biol Med (Maywood); 2002 Dec; 227(11):957-68. PubMed ID: 12486205
[TBL] [Abstract][Full Text] [Related]
31. The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.
Lutfy K; Zaveri NT
Prog Mol Biol Transl Sci; 2016; 137():149-81. PubMed ID: 26810001
[TBL] [Abstract][Full Text] [Related]
32. Opioids for hedonic experience and dopamine to get ready for it.
Barbano MF; Cador M
Psychopharmacology (Berl); 2007 Apr; 191(3):497-506. PubMed ID: 17031710
[TBL] [Abstract][Full Text] [Related]
33. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.
Koob GF
Pharmacol Rev; 2021 Jan; 73(1):163-201. PubMed ID: 33318153
[TBL] [Abstract][Full Text] [Related]
34. Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms.
Carr KD
Physiol Behav; 2002 Jul; 76(3):353-64. PubMed ID: 12117572
[TBL] [Abstract][Full Text] [Related]
35. Endogenous opioid systems alterations in pain and opioid use disorder.
Higginbotham JA; Markovic T; Massaly N; Morón JA
Front Syst Neurosci; 2022; 16():1014768. PubMed ID: 36341476
[TBL] [Abstract][Full Text] [Related]
36. Reward processing by the opioid system in the brain.
Le Merrer J; Becker JA; Befort K; Kieffer BL
Physiol Rev; 2009 Oct; 89(4):1379-412. PubMed ID: 19789384
[TBL] [Abstract][Full Text] [Related]
37. Ethanol as a neurochemical surrogate of conventional reinforcers: the dopamine-opioid link.
Di Chiara G; Acquas E; Tanda G
Alcohol; 1996; 13(1):13-7. PubMed ID: 8837928
[TBL] [Abstract][Full Text] [Related]
38. Ring of Power: A Band of Peptidergic Midbrain Neurons that Binds Motivation.
Collins AL; Wolff AR; Saunders BT
Neuron; 2019 Aug; 103(3):364-366. PubMed ID: 31394061
[TBL] [Abstract][Full Text] [Related]
39. Adaptive Changes in the Central Control of Energy Homeostasis Occur in Response to Variations in Energy Status.
Gastelum C; Perez L; Hernandez J; Le N; Vahrson I; Sayers S; Wagner EJ
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800452
[TBL] [Abstract][Full Text] [Related]
40. Orphanin FQ/Nociceptin and the mystery of pain.
Brundege JM
Neuron; 2000 May; 26(2):282-5. PubMed ID: 10839345
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
